scholarly article | Q13442814 |
P50 | author | Bernard Moss | Q822617 |
P2093 | author name string | Earl PL | |
Weir JP | |||
Rosel JL | |||
P2860 | cites work | Vaccinia virus thymidine kinase and neighboring genes: mRNAs and polypeptides of wild-type virus and putative nonsense mutants | Q36928641 |
Fine structure analysis and nucleotide sequence of the vaccinia virus thymidine kinase gene | Q37613937 | ||
One hundred base pairs of 5' flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription | Q37683326 | ||
HindIII and Sst I restriction sites mapped on rabbit poxvirus and vaccinia virus DNA | Q39980857 | ||
Isolation of DNA from agarose gels using DEAE-paper. Application to restriction site mapping of adenovirus type 16 DNA. | Q40498715 | ||
Nucleotide sequence of a cluster of early and late genes in a conserved segment of the vaccinia virus genome | Q40567989 | ||
In vitro translation of immediate early, early, and late classes of RNA from vaccinia virus-infected cells | Q41713595 | ||
Cell-free translation of early and late mRNAs selected by hybridization to cloned DNA fragments derived from the left 14 million to 72 million daltons of the vaccinia virus genome | Q43631768 | ||
Definition of a novel promoter for the major adenovirus-associated virus mRNA. | Q45234568 | ||
Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene | Q45791797 | ||
Methylated 5'-terminal sequences of vaccinia virus mRNA species made in vivo at early and late times after infection | Q45887767 | ||
A rapid alkaline extraction procedure for screening recombinant plasmid DNA | Q24614998 | ||
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing | Q27860486 | ||
Rapid and sensitive protein similarity searches | Q27860496 | ||
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs | Q27860573 | ||
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes | Q27860600 | ||
Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing | Q27860941 | ||
A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments | Q29618189 | ||
Extension of the transcriptional and translational map of the left end of the vaccinia virus genome to 21 kilobase pairs. | Q35240558 | ||
Homology between RNA polymerases of poxviruses, prokaryotes, and eukaryotes: nucleotide sequence and transcriptional analysis of vaccinia virus genes encoding 147-kDa and 22-kDa subunits | Q35604109 | ||
Homology between DNA polymerases of poxviruses, herpesviruses, and adenoviruses: nucleotide sequence of the vaccinia virus DNA polymerase gene | Q35607469 | ||
Isolation and characterization of monoclonal antibodies directed against two subunits of rabbit poxvirus-associated, DNA-directed RNA polymerase. | Q36423664 | ||
Intermolecular duplexes formed from polyadenylylated vaccinia virus RNA. | Q36497272 | ||
Mechanism of Synthesis of Vaccinia Virus Double-Stranded Ribonucleic Acid In Vivo and In Vitro | Q36577589 | ||
Transcription of vaccinia virus early genes by a template-dependent soluble extract of purified virions | Q36852325 | ||
Use of a bacterial expression vector to identify the gene encoding a major core protein of vaccinia virus | Q36853159 | ||
Transcriptional and translational mapping and nucleotide sequence analysis of a vaccinia virus gene encoding the precursor of the major core polypeptide 4b | Q36854635 | ||
Vaccinia virus induces ribonucleotide reductase in primate cells | Q36895714 | ||
In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals | Q36900146 | ||
A soluble transcription system derived from purified vaccinia virions | Q36904173 | ||
Nucleotide sequence of the vaccinia virus thymidine kinase gene and the nature of spontaneous frameshift mutations | Q36905981 | ||
Arrangement of late RNAs transcribed from a 7.1-kilobase EcoRI vaccinia virus DNA fragment | Q36912162 | ||
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. | Q36913229 | ||
Regulation of expression and nucleotide sequence of a late vaccinia virus gene | Q36918833 | ||
Restriction enzyme mapping of vaccinia virus DNA | Q36922113 | ||
Complete nucleotide sequences of two adjacent early vaccinia virus genes located within the inverted terminal repetition. | Q36926805 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Vaccinia virus | Q1986297 |
P304 | page(s) | 436-449 | |
P577 | publication date | 1986-11-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment | |
P478 | volume | 60 |
Q35849628 | A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates |
Q33782698 | A cellular protein binds vaccinia virus late promoters and activates transcription in vitro |
Q36831606 | A comparison of the genome organization of capripoxvirus with that of the orthopoxviruses. |
Q33546567 | A homolog of the vaccinia virus D13L rifampicin resistance gene is in the entomopoxvirus of the parasitic wasp, Diachasmimorpha longicaudata |
Q53689031 | A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis. |
Q35154570 | A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers. |
Q43604537 | A prominent antigenic surface polypeptide involved in the biogenesis and function of the vaccinia virus envelope |
Q42132409 | A targeted approach to identification of vaccinia virus postreplicative transcription elongation factors: genetic evidence for a role of the H5R gene in vaccinia transcription |
Q35990356 | Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen |
Q45851156 | Activity of a fowlpox virus late gene promoter in vaccinia and fowlpox virus recombinants |
Q33907236 | Attenuation of vaccinia virus by the expression of human Flt3 ligand |
Q36779657 | Biochemical and biophysical properties of a putative hub protein expressed by vaccinia virus |
Q36780159 | Capped poly(A) leaders of variable lengths at the 5' ends of vaccinia virus late mRNAs |
Q37341397 | Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters |
Q36697464 | Characterization of a 7-kilodalton subunit of vaccinia virus DNA-dependent RNA polymerase with structural similarities to the smallest subunit of eukaryotic RNA polymerase II. |
Q40066985 | Characterization of a molluscum contagiosum virus homolog of the vaccinia virus p37K major envelope antigen |
Q33809797 | Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail |
Q40545320 | Cis-acting sequences affecting the length of the poly(A) head of vaccinia virus late transcripts |
Q40116789 | Cloning and expression of foreign genes in vaccinia virus, using a host range selection system |
Q33799135 | Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesis |
Q40108953 | Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity |
Q33212560 | Comparative analysis of selected genes from Diachasmimorpha longicaudata entomopoxvirus and other poxviruses |
Q36118625 | Conserved sequences near the early transcription start sites of vaccinia virus |
Q36874877 | Construction and application of plasmids containing bidirectional promoters of vaccinia virus |
Q35595612 | Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein. |
Q44139432 | Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer. |
Q36828459 | DNA sequences that regulate expression of a vaccinia virus late gene (L65) and interact with a DNA-binding protein from infected cells |
Q35611968 | Deciphering poxvirus gene expression by RNA sequencing and ribosome profiling |
Q36906810 | Determination of the transcriptional regulatory region of a vaccinia virus late gene |
Q36868255 | Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors |
Q36830970 | Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals |
Q36780690 | Fine structure mapping of five temperature-sensitive mutants in the 22- and 147-kilodalton subunits of vaccinia virus DNA-dependent RNA polymerase |
Q42655170 | Fine structure of the vaccinia virus gene encoding the precursor of the major core protein 4 a. |
Q33837349 | Fowlpox virus encodes a novel DNA repair enzyme, CPD-photolyase, that restores infectivity of UV light-damaged virus |
Q48133582 | Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes |
Q40372624 | Functional organization of variola major and vaccinia virus genomes |
Q36796061 | Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env. |
Q36830683 | Genetic evidence for involvement of vaccinia virus DNA-dependent ATPase I in intermediate and late gene expression |
Q35946213 | Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model |
Q40064533 | Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress |
Q36690596 | Identification and expression of rpo19, a vaccinia virus gene encoding a 19-kilodalton DNA-dependent RNA polymerase subunit |
Q40389766 | Identification by a random sequencing strategy of the fowlpoxvirus DNA polymerase gene, its nucleotide sequence and comparison with other viral DNA polymerases |
Q34357613 | Identification of a vaccinia virus gene encoding a type I DNA topoisomerase |
Q36830987 | Identification of factors specific for transcription of the late class of vaccinia virus genes |
Q36729125 | Identification of rpo30, a vaccinia virus RNA polymerase gene with structural similarity to a eucaryotic transcription elongation factor |
Q34355408 | Identification of the orthopoxvirus p4c gene, which encodes a structural protein that directs intracellular mature virus particles into A-type inclusions |
Q36808327 | Identification of the vaccinia virus gene encoding an 18-kilodalton subunit of RNA polymerase and demonstration of a 5' poly(A) leader on its early transcript. |
Q35076857 | Identification of the vaccinia virus gene encoding nucleoside triphosphate phosphohydrolase I, a DNA-dependent ATPase |
Q36827966 | Identification, cloning, and sequencing of a fragment of Amsacta moorei entomopoxvirus DNA containing the spheroidin gene and three vaccinia virus-related open reading frames. |
Q44153796 | Immunological and virological characterization of improved construction of recombinant vaccinia virus expressing rinderpest virus hemagglutinin |
Q45880152 | In vitro recognition of an orf virus early promoter in a vaccinia virus extract |
Q34376700 | In vitro synthesis of vaccinia virus late mRNA containing a 5' poly(A) leader sequence. |
Q36798603 | Increased expression in vivo and in vitro of foreign genes directed by A-type inclusion body hybrid promoters in recombinant vaccinia viruses |
Q45850335 | Intracellular processing and immunogenicity of the envelope proteins of human T-cell leukemia virus type I that are expressed from recombinant vaccinia viruses |
Q34120696 | Introduction of the Six Major Genomic Deletions of Modified Vaccinia Virus Ankara (MVA) into the Parental Vaccinia Virus Is Not Sufficient To Reproduce an MVA-Like Phenotype in Cell Culture and in Mice |
Q36890933 | Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes |
Q36798711 | L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines |
Q36288076 | Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein |
Q33929995 | Messenger RNAs of a strongly-expressed late gene of cowpox virus contain 5'-terminal poly(A) sequences |
Q36701060 | Molecular characterization of the vaccinia virus hemagglutinin gene |
Q36826445 | Molecular dissection of cis-acting regulatory elements from 5'-proximal regions of a vaccinia virus late gene cluster |
Q36699665 | Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters |
Q36887284 | Nucleotide sequence and transcript organization of a region of the vaccinia virus genome which encodes a constitutively expressed gene required for DNA replication |
Q42643818 | Nucleotide sequence and transcriptional studies of the vaccinia virus KpnI I DNA fragment |
Q34345472 | Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes |
Q45752258 | Orf virus encodes a homolog of the vaccinia virus interferon-resistance gene E3L. |
Q36074391 | Orthopoxvirus targets for the development of antiviral therapies |
Q37173398 | Orthopoxvirus targets for the development of new antiviral agents. |
Q36225693 | Pervasive initiation and 3'-end formation of poxvirus postreplicative RNAs |
Q33930815 | Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals |
Q56340225 | Poxviral promoters for improving the immunogenicity of MVA delivered vaccines |
Q33826983 | Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect |
Q33803714 | Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. |
Q45876943 | Quantitative assessment of poxvirus promoters in fowlpox and vaccinia virus recombinants |
Q36960175 | RNA polymerase-associated transcription specificity factor encoded by vaccinia virus |
Q36651987 | Reactivation of transcription from a vaccinia virus early promoter late in infection |
Q36918751 | Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice |
Q33780579 | Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus. |
Q30978284 | Salmon Gill Poxvirus, the Deepest Representative of the Chordopoxvirinae |
Q36326524 | Sequence and transcriptional analysis of the vaccinia virus HindIII I fragment |
Q33953053 | Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing |
Q33937787 | Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor |
Q36812348 | Structure and expression of the vaccinia virus gene which prevents virus-induced breakdown of RNA. |
Q36702030 | Temperature-sensitive mutations in the vaccinia virus H4 gene encoding a component of the virion RNA polymerase |
Q38288824 | The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro. |
Q24516950 | The genome of Melanoplus sanguinipes entomopoxvirus |
Q39590582 | The genome of fowlpox virus |
Q41874700 | The nature of naturally occurring mutations in the hemagglutinin gene of vaccinia virus and the sequence of immediately adjacent genes |
Q24679648 | The scanning model for translation: an update |
Q36781417 | The second-largest subunit of the poxvirus RNA polymerase is similar to the corresponding subunits of procaryotic and eucaryotic RNA polymerases |
Q33811821 | The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis |
Q35870032 | The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression. |
Q36831540 | Transcription of a poxvirus early gene is regulated both by a short promoter element and by a transcriptional termination signal controlling transcriptional interference |
Q40539060 | Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases |
Q40043683 | Transcriptional mapping of a late gene coding for the p12 attachment protein of African swine fever virus. |
Q33849466 | Transfer of the inducible lac repressor/operator system from Escherichia coli to a vaccinia virus expression vector |
Q36656392 | Transient expression of the vaccinia virus DNA polymerase is an intrinsic feature of the early phase of infection and is unlinked to DNA replication and late gene expression |
Q58092266 | Translational control during poxvirus infection |
Q36796095 | Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25 |
Q36797598 | Utilization of DNA recombination for the two-step replacement of growth factor sequences in the vaccinia virus genome |
Q33770781 | Vaccinia H5 is a multifunctional protein involved in viral DNA replication, postreplicative gene transcription, and virion morphogenesis |
Q34347131 | Vaccinia virus J1R protein: a viral membrane protein that is essential for virion morphogenesis |
Q36933959 | Vaccinia virus WR53.5/F14.5 protein is a new component of intracellular mature virus and is important for calcium-independent cell adhesion and vaccinia virus virulence in mice |
Q37700653 | Vaccinia virus directs the synthesis of early mRNAs containing 5' poly(A) sequences |
Q40537769 | Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping |
Q33801656 | Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo |
Q35835061 | Vaccinia virus gene H5R encodes a protein that is phosphorylated by the multisubstrate vaccinia virus B1R protein kinase. |
Q34090814 | Vaccinia virus gene encoding a 30-kilodalton subunit of the viral DNA-dependent RNA polymerase |
Q36803263 | Vaccinia virus gene encoding a component of the viral early transcription factor |
Q36645421 | Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component |
Q37511614 | Vaccinia virus mutants with alanine substitutions in the conserved G5R gene fail to initiate morphogenesis at the nonpermissive temperature |
Q43521091 | Vaccinia virus recombinants expressing rabiesvirus glycoprotein protect against rabies |
Q36826879 | Vaccinia virus-encoded ribonucleotide reductase: sequence conservation of the gene for the small subunit and its amplification in hydroxyurea-resistant mutants |
Q37380398 | Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition |
Q39020471 | Yeast virus-derived stimulator of the innate immune system augments the efficacy of virus vector-based immunotherapy. |
Search more.